Microfluidics-Based Detection Platform for Circulating Tumor Cells and Its Applications in Cancer Early Screening and Disease Monitoring led by Professor Michael Yang Mengsu, Yeung Kin Man Chair Professor of Biomedical Sciences. The research team is committed to developing an internationally leading fourth-generation Circulating Tumor Cells (CTC) detection technology platform with compatible gene and protein detection assay kits for downstream CTC analysis. The project aims to fulfil clinical demand in cancer prevention, diagnosis and treatment.